In our study we have shown that even though IL6 C-174G gene polymorphism was not associated with the risk of depression, there was an interaction between IL-6 high producer G allele carriers and baseline depressive symptoms, conferring together higher risk of depressive episode in the course of antiviral treatment in CHC patients. Here, IL6 is linked to depressive symptom measurement.